Visual And Refractive Outcomes And Patient Satisfaction After Phacoemulsification And Extended Depth Of Focus (Edof) Intraocular Lens Implantation In Guatemala.
Published 2023 - 41st Congress of the ESCRS
Reference: PO0505 | Type: Free paper | DOI: 10.82333/11mf-8587
Authors: Alvaro Juan Pablo JUAN PABLO Tovar Gomez* 1 , Victor José Romero 1 , Jenifer Gabriela López Guillermo 1 , Damariz Pamela Guzmán Zárate 1
1Ophthalmology ,National Ophthalmology Unit,Guatemala,Guatemala
Purpose
To assess visual and refractive outcomes and patient satisfaction after phacoemulsification and extended depth of focus (EDOF) intraocular (IOL) lens implantation in Guatemala. To compare two different EDOF IOL models in terms of patient satisfaction and visual and refractive outcomes
Setting
National Ophthalmology Unit, Guatemala City, Central America
Methods
Prospective non randomize trial of patients who underwent phacoemulsification and EDOF IOL implantation of two different models, surgery performed by the same surgeon. Patients assigned to have phacoemulsification + EMV IOL (Rayner®, UK) and phacoemulsification + Eyhance IOL (J&J, USA) in both eyes. Micro monovision was pursued in non dominat eye (-0.75 offset). Pre/Post-operative uncorrected (UCVA), best corrected visual acuity (BCVA), refraction and defocus curve were obtained at final consult. Postoperative complications were reported. Chi-square test, T test and variance analysis were used with significance defined as p<0.05. For patient satisfaction measurement, the Visual Function Index 14 questionnaire (VF-14) was used.
Results
Eighty-eight eyes of forty-four patients were analyzed from Jan 2022 to Dec 2022, average follow up was 11.3 months. Mean age was 67.7 years (SD+/- 8.75) 70% were females. There was not statistical difference in clinical characteristics among both groups. After phacoemulsification and EDOF IOL implantation UCVA, BCDVA and spherical equivalent improved (p>0.05) in both groups. No complications were reported during the study period. Defocus curve was plotted. VF-14 questionnaire showed high percentage of satisfaction in both groups. No statistically difference was shown among groups.
Conclusions
After phacoemulsification Bilateral UCDVA and Bilateral BCDVA improved with EDOF IOL implantation. High percentage of satisfaction was also achieved. These results suggest that EDOF implantation in a cohort of Guatemalan patients seems to be an effective and safe procedure but more patient data and prospective clinical trials are needed, along with long term follow-up.